Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Palleon Pharmaceuticals
266 Second Avenue
Waltham, MA 02451
Phone: 857-285-5900
http://palleonpharma.com/

Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. The company's proprietary Convergence Platform integrates technologies and insights from world-renowned scientific leaders in the fields of glycoscience and human immunology to create a novel approach to treating cancer. By targeting multiple immune cell types, Glycoimmune Checkpoint inhibitors will tackle resistance to first-generation immuno-oncology agents, and make possible a wider range of rational combination therapies to treat cancer. While Palleon is focused primarily on oncology, the Convergence Platform is applicable to other therapeutic areas including infectious diseases, neurodegeneration, inflammation, and fibrosis.

Key Contact
Name
Jim Broderick
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/04/17 $47,600,000 Series A AbbVie Biotech Ventures
Pfizer Venture Investments
SR One
Takeda Ventures
Vertex Ventures
undisclosed
09/17/20 $100,000,000 Series B AbbVie Biotech Ventures
Matrix Capital Management
Pfizer Venture Investments
SR One
Surveyor Capital
Takeda Ventures
Vertex Ventures
undisclosed